PCCI’s 7th Annual Roundtable “Crowdfunding for Life Sciences: A Bridge Over Troubled Waters?”
Reporter: Stephen J. Williams, Ph.D.
Article ID #130: PCCI’s 7th Annual Roundtable “Crowdfunding for Life Sciences: A Bridge Over Troubled Waters?” May 12 2014 Embassy Suites Hotel, Chesterbrook PA 6:00-9:30 PM. Published on 4/17/2014
WordCloud Image Produced by Adam Tubman
http://www.rxpcci.com/meetings.htm
Monday, May 12 2014 Embassy Suites Hotel, Chesterbrook PA 6:00 -9:30 PM
Pharmaceutical Consulting Consortium International Inc. presents their 7th annual Roundtable on Crowdfunding for the Life Sciences and how this funding mechanism applies to early stage life science companies and changes the funding landscape. The conference will examine the types of crowdfunding out there and attempts to answer many questions including:
- Which one is right for which new companies at which stage of the funding process?
- And how will choosing the right or wrong one influence follow-on funders and funding rounds?
- Will the advent of crowdfunding speed up the investment process?
- Will it really bridge the yawning “valley of death”?
The panel is made up of notables and practitioners who will be called upon to deal with the pros and cons of crowdfunding in real life and let them discuss how all this is likely to apply to life science entrepreneurs and investors.
The panel includes:
- Mark Roderick, Attorney Flaster/Greenberg PC (Moderator)
- Valerie Gaydos, President, Capital Growth (represents angel/venture community)
- Samuel Wertheimer, Chief Investment Officer, Poliwogg Darrick Mix
- Duane Morris, LLP (journalist who covers crowdfunding
Register by clicking on www.rxpcci.com and following directions The event will be webcast.
Leaders in Pharmaceutical Business Intelligence had recently launched a new, real-time based methodology for meeting coverage using social media as a platform to foster discussion and commentary.
This methodology is described in the following post REAL TIME Cancer Conference Coverage: A Novel Methodology for Authentic Reporting on Presentations and Discussions launched via Twitter.com @ The 2nd ANNUAL Sachs Cancer Bio Partnering & Investment Forum in Drug Development, 19th March 2014 • New York Academy of Sciences • USA
This new method was successfully used and curated at the 2nd Annual Sachs Cancer Bio Partnering &Investment Forum at the New York Academy of Sciences and will be featured at the forthcoming Sachs Global Conferences in 2014 and 2015.
Related articles on this site include:
conceived: NEW Definition for Co-Curation in Medical Research
Cancer Biology and Genomics for Disease Diagnosis, Volume One Pre-ePub Announcement
Volatile Organic Compounds (VOCs) as Biomarkers in Cancer Detection: • Alnion Ranked #1 in “Top 10 Israeli medical advances to watch in 2014”.
Investing and inventing: Is the Tango of Mars and Venus Still on
SACHS Associates, London – Planning Forthcoming Conferences: 2014 – 2015
2012pharmaceutical
sjwilliamspa